Delay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients.

The article offers information on the glioblastoma multiforme (GBM), the commonest primary brain malignant tumor eludes a cure. It mentions that radiotherapy (RT) has consistently shown to improve OS compared to best supportive care in GBM patients; and also mentions that patients who were alive at the time of last follow-up were classified as censored observations.